Diabetes, Vol 42, Issue 5 662-669, Copyright © 1993 by American Diabetes Association

ARTICLES

Effect of dehydroepiandrosterone on neurotransmitter levels and appetite regulation of the obese Zucker rat. The Obesity Research Program

JM Abadie, B Wright, G Correa, ES Browne, JR Porter and F Svec
Department of Medicine, Louisiana State University Medical Center, New Orleans.

The obese Zucker rat is a model of youth-onset obesity associated with hyperphagia. In this study, dehydroepiandrosterone's effect at decreasing food intake and body weight in the obese Zucker rat was investigated. Rats were treated with a dehydroepiandrosterone-supplemented diet (0.0, 0.06, 0.15, 0.3, or 0.6%) for 7 days. The 0.3 and 0.6% treatment groups showed a dramatic decrease in daily food intake, which was evident the 1st day. In addition to the reduction in food intake, body weight changes also were affected significantly in the high-dose treatment groups. The possibility that these dehydroepiandrosterone-induced changes were correlated to perturbations in central neurotransmitter levels associated with appetite control was investigated. The hypothalamus, frontal cortex, striatum, and hippocampus of dehydroepiandrosterone-treated animals were assayed for neurotransmitters known to have inhibitory or stimulatory effects on feeding behavior (serotonin, dopamine, norepinephrine, and epinephrine). Significant differences from steroid-free controls were noted only in the levels of hypothalamic serotonin in animals treated with dehydroepiandrosterone. Serotonin in the hypothalamus has been shown to decrease feeding behavior. The magnitude of dehydroepiandrosterone's effect on hypothalamic serotonin correlated with its effect on feeding behavior. Thus, dehydroepiandrosterone may reduce hyperphagia by altering hypothalamic levels of serotonin.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Porter, M. Van Vrancken, C. Corll, H. Thompson, and F. Svec The influence of dehydroepiandrosterone and 8-OH-DPAT on the caloric intake and hypothalamic neurotransmitters of lean and obese Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R928 - R935. [Abstract] [Full Text] [PDF]

				P. J. Schmidt, R. C. Daly, M. Bloch, M. J. Smith, M. A. Danaceau, L. Simpson St. Clair, J. H. Murphy, N. Haq, and D. R. Rubinow Dehydroepiandrosterone Monotherapy in Midlife-Onset Major and Minor Depression Arch Gen Psychiatry, February 1, 2005; 62(2): 154 - 162. [Abstract] [Full Text] [PDF]

				F. Catalina, L. Milewich, V. Kumar, and M. Bennett Dietary Dehydroepiandrosterone Inhibits Bone Marrow and Leukemia Cell Transplants: Role of Food Restriction Experimental Biology and Medicine, December 1, 2003; 228(11): 1303 - 1320. [Abstract] [Full Text] [PDF]

				N. Hiroi, T. Ichijo, H. Ueshiba, and Y. Miyachi Intranasal Administration of Adrenocorticotropin-(1-24) Stimulates Adrenocortical Hormone Secretion J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1750 - 1753. [Abstract] [Full Text] [PDF]

				J. M. Abadie, G. T. Malcom, J. R. Porter, and F. Svec Dehydroepiandrosterone Alters Zucker Rat Soleus and Cardiac Muscle Lipid Profiles Experimental Biology and Medicine, September 1, 2001; 226(8): 782 - 789. [Abstract] [Full Text] [PDF]

				F. Catalina, S. G. Speciale, V. Kumar, L. Milewich, and M. Bennett Food Restriction-like Effects of Dietary Dehydroepiandrosterone. Hypothalamic Neurotransmitters and Metabolites in Male C57BL/6 and (C57BL/6 DBA/2)F1 Mice Experimental Biology and Medicine, March 1, 2001; 226(3): 208 - 215. [Abstract] [Full Text]

				P. Monteleone, M. Luisi, B. Colurcio, E. Casarosa, P. Monteleone, R. Ioime, A. R. Genazzani, and M. Maj Plasma Levels of Neuroactive Steroids Are Increased in Untreated Women With Anorexia Nervosa or Bulimia Nervosa Psychosom Med, January 1, 2001; 63(1): 62 - 68. [Abstract] [Full Text] [PDF]

				W. Arlt, F. Callies, J. C. van Vlijmen, I. Koehler, M. Reincke, M. Bidlingmaier, D. Huebler, M. Oettel, M. Ernst, H. M. Schulte, et al. Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency N. Engl. J. Med., September 30, 1999; 341(14): 1013 - 1020. [Abstract] [Full Text] [PDF]

				O. M. Wolkowitz, V. I. Reus, A. Keebler, N. Nelson, M. Friedland, L. Brizendine, and E. Roberts Double-Blind Treatment of Major Depression With Dehydroepiandrosterone Am J Psychiatry, April 1, 1999; 156(4): 646 - 649. [Abstract] [Full Text]

				M. Kimura, S.-i. Tanaka, Y. Yamada, Y. Kiuchi, T. Yamakawa, and H. Sekihara Dehydroepiandrosterone Decreases Serum Tumor Necrosis Factor-{alpha} and Restores Insulin Sensitivity: Independent Effect from Secondary Weight Reduction in Genetically Obese Zucker Fatty Rats Endocrinology, July 1, 1998; 139(7): 3249 - 3253. [Abstract] [Full Text] [PDF]